Pfizer Inc. (PFE)
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.
Pfizer names Chris Boshoff as new R&D chief, WSJ reports
Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer's cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Is It Time to Sell Eli Lilly and Pfizer Stocks?
If I Could Only Buy 2 High Dividend Yield Companies In November 2024: Both Yield Above 6%
I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Both pay an attractive Dividend Yield [FWD] of 6.14% (Pfizer) and 6.58% (Verizon) and have a relatively low Valuation (P/E Non-GAAP [FWD] Ratio of 9.34 (Pfizer) and 8.80 (Verizon). To reduce the company-specific concentration risk of your investment portfolio, I suggest setting an allocation limit of 3% for both companies.
Pfizer loses bid to recoup $75 million left over from SEC settlement
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission settlement with billionaire Steven A. Cohen's hedge fund SAC Capital in an insider trading case.
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
On Monday, BridgeBio Pharma, Inc. BBIO presented initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association Scientific Sessions.
2 High-Yield Dividend Stocks I Can't Stop Buying
2 High-Yield Dividend Stocks I Can't Stop Buying
Stock Of The Day: Is Pfizer Set Up To Rally?
Pfizer Inc. PFE shares are lower on Thursday due to news that President-elect Donald Trump picked Robert F. Kennedy Jr. as his next secretary of the Department of Health and Human Services.
Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
